In fact, we found the same exacerbation of COPD pathology in Cars2+/− mice treated with CSExt (Fig. 8a–c), in which both inflammatory responses and cellular senescence were significantly increased (Fig. 8d, e). Here, CARS2 is linked to chronic obstructive pulmonary disease.